GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Serina Therapeutics Inc (AMEX:SER) » Definitions » Additional Paid-In Capital

Serina Therapeutics (Serina Therapeutics) Additional Paid-In Capital : $1.13 Mil(As of Mar. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Serina Therapeutics Additional Paid-In Capital?


Serina Therapeutics's quarterly additional paid-in capital increased from Dec. 2022 ($0.65 Mil) to Jun. 2023 ($0.67 Mil) and increased from Jun. 2023 ($0.67 Mil) to Mar. 2024 ($1.13 Mil).

Serina Therapeutics's annual additional paid-in capital increased from . 20 ($0.00 Mil) to Dec. 2021 ($0.64 Mil) and increased from Dec. 2021 ($0.64 Mil) to Dec. 2022 ($0.65 Mil).

Serina Therapeutics Additional Paid-In Capital Historical Data

The historical data trend for Serina Therapeutics's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Serina Therapeutics Additional Paid-In Capital Chart

Serina Therapeutics Annual Data
Trend Dec21 Dec22
Additional Paid-In Capital
0.64 0.65

Serina Therapeutics Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Mar24
Additional Paid-In Capital 0.64 - 0.65 0.67 1.13

Serina Therapeutics Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Serina Therapeutics Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Serina Therapeutics's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Serina Therapeutics (Serina Therapeutics) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Serina Therapeutics Inc (AMEX:SER) » Definitions » Additional Paid-In Capital
Comparable Companies
Traded in Other Exchanges
2BO:Germany
Address
601 Genome Way, Suite 2001, Huntsville, AL, USA, 35806
Website
https://www.serinatherapeutics.com
Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers.

Serina Therapeutics (Serina Therapeutics) Headlines

From GuruFocus

Enable Injections and Serina Therapeutics Announce Agreement to Develop SER-252 in Combination with enFuse� for Advanced Parkinson's Disease

By Marketwired • 05-15-2024